MiR-192 attenuates high glucose-induced pyroptosis in retinal pigment epithelial cells via inflammasome modulation

Cao Gu1, Hongjun Zhang2, Qing Li1

  • 1Department of Ophthalmology, Changhai Hospital, First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai, China.

Bioengineered
|April 20, 2022
PubMed

Insights

MicroRNA-192 (miR-192) prevents high glucose-induced pyroptosis in retinal cells by targeting FTO/NLRP3 signaling. This finding offers a new therapeutic target for diabetic retinopathy.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic retinopathy is a diabetes complication where pyroptosis is key.
  • MicroRNA-192 (miR-192) is implicated in diabetic retinopathy, but its role in pyroptosis is unknown.

Purpose of the Study:

  • To investigate the role and mechanism of miR-192 in high glucose-induced pyroptosis of retinal pigment epithelial (RPE) cells.

Main Methods:

  • Cells were treated with high glucose (HG) to induce pyroptosis.
  • miR-192 expression, FTO (α-ketoglutarate-dependent dioxygenase), and NLRP3 inflammasome activation were analyzed.
  • Bioinformatics, dual-luciferase reporter, and RNA pull-down assays identified FTO as a direct miR-192 target.

Main Results:

  • HG induced RPE cell pyroptosis and decreased miR-192 expression.
  • miR-192 overexpression inhibited HG-induced pyroptosis.
  • FTO was confirmed as a direct target of miR-192, and its upregulation reversed miR-192's protective effects.
  • FTO promoted NLRP3 expression via demethylation, enhancing pyroptosis.

Conclusions:

  • miR-192 suppresses HG-induced RPE cell pyroptosis by inhibiting the FTO/NLRP3 pathway.
  • This study elucidates a novel mechanism for diabetic retinopathy and suggests miR-192 as a potential therapeutic target.

Related Concept Videos